AHA 2018: The Latest Updates on CVOT Data for Type 2 DM Therapies

Published: 21 Nov 2018

  • Views:

    Views Icon 537
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating


Prof Carolyn Lam (National Heart Center, SG) & Prof John McMurray (University of Glasgow, UK) discuss the latest updates on CVOT data for Type 2 DM therapies.


Filmed by Radcliffe Cardiology on site at AHA 2018.

This peer-to-peer discussion was funded by an unrestricted grant by Novo Nordisk.